1. Home
  2. IMCC vs SILO Comparison

IMCC vs SILO Comparison

Compare IMCC & SILO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMCC
  • SILO
  • Stock Information
  • Founded
  • IMCC 1980
  • SILO 2010
  • Country
  • IMCC Israel
  • SILO United States
  • Employees
  • IMCC N/A
  • SILO N/A
  • Industry
  • IMCC Medicinal Chemicals and Botanical Products
  • SILO Apparel
  • Sector
  • IMCC Health Care
  • SILO Consumer Discretionary
  • Exchange
  • IMCC Nasdaq
  • SILO Nasdaq
  • Market Cap
  • IMCC 7.5M
  • SILO 8.8M
  • IPO Year
  • IMCC N/A
  • SILO N/A
  • Fundamental
  • Price
  • IMCC $2.37
  • SILO $1.65
  • Analyst Decision
  • IMCC
  • SILO
  • Analyst Count
  • IMCC 0
  • SILO 0
  • Target Price
  • IMCC N/A
  • SILO N/A
  • AVG Volume (30 Days)
  • IMCC 16.9K
  • SILO 805.4K
  • Earning Date
  • IMCC 03-27-2025
  • SILO 02-18-2025
  • Dividend Yield
  • IMCC N/A
  • SILO N/A
  • EPS Growth
  • IMCC N/A
  • SILO N/A
  • EPS
  • IMCC N/A
  • SILO N/A
  • Revenue
  • IMCC $38,042,859.00
  • SILO $72,102.00
  • Revenue This Year
  • IMCC $22.59
  • SILO $1.86
  • Revenue Next Year
  • IMCC $32.86
  • SILO N/A
  • P/E Ratio
  • IMCC N/A
  • SILO N/A
  • Revenue Growth
  • IMCC N/A
  • SILO N/A
  • 52 Week Low
  • IMCC $1.41
  • SILO $0.77
  • 52 Week High
  • IMCC $8.10
  • SILO $4.50
  • Technical
  • Relative Strength Index (RSI)
  • IMCC 53.35
  • SILO 52.57
  • Support Level
  • IMCC $2.05
  • SILO $1.56
  • Resistance Level
  • IMCC $2.60
  • SILO $1.89
  • Average True Range (ATR)
  • IMCC 0.21
  • SILO 0.19
  • MACD
  • IMCC 0.02
  • SILO -0.05
  • Stochastic Oscillator
  • IMCC 58.31
  • SILO 27.12

About IMCC IM Cannabis Corp.

IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.

About SILO Silo Pharma Inc.

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.

Share on Social Networks: